Herliawati, P. A. . (2023) “Malignancy Risk Index 4 (RMI 4) is better than RMI 3 as a predictor Advanced Epithelial Ovarian Carcinoma was used for NACT”, Jurnal Ners, 7(1), pp. 536–542. doi: 10.31004/jn.v7i1.13495.